Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Hide What is the GOLO return policy
Peer review Peer review information Nature Reviews Drug Discovery thanks Timo Mller and the other anonymous reviewer/s for their contribution to the peer review of this manuscript
Obesity Clinical Development Pipeline Muscle and Body Composition Other assets focused on preventing muscle loss in combination with incretin mimetics include Regenerons Phase 2 trevogrumab (myostatin) + garetosmab (ActA) combination, BioAges Phase 2 azelaprag (APJ), and Scholar Rocks Phase 2 apitegromab (myostatin)
It remains in clinical trials globally, with Phase 3 studies ongoing
Our expert medspa team is ready to help you secure your health progress.
Metabolic testing: Unlock the secrets to your body's unique metabolism with our comprehensive metabolic testing, which will help us create a tailored plan that works best for you
